EMILY CASH: Open Payments
NPI 1669171641 · BOWLING GREEN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,269 in 181 payments from 19 companies in 2025. Trend: 2023 $172 · 2024 $2,856 · 2025 $3,269
Food & beverage: $3,197Education: $71
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $596 |
| Otsuka America Pharmaceutical, Inc. | 16 | $309 |
| Neurocrine BioSciences, Inc. | 18 | $282 |
| Axsome Therapeutics, Inc. | 11 | $281 |
| E.R. Squibb & Sons, L.L.C. | 11 | $275 |
| Alkermes, Inc. | 17 | $243 |
| Vanda Pharmaceuticals Inc. | 11 | $236 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $227 |
| Collegium Pharmaceutical, Inc. | 16 | $215 |
| Teva Pharmaceuticals USA, Inc. | 7 | $191 |
Products named: VRAYLAR, INGREZZA, Auvelity, COBENFY, FANAPT, REXULTI, CAPLYTA, ARISTADA.
Industry payments across KY — which companies pay providers there.
